ETHACRYNIC ACID, Etacrynic Acid, 58-54-8, ethacrynate, Etacrinic acid, Edecrin, Hydromedin, Taladren, Crinuryl, Edecril, Edecrina, Endecril, Hidromedin, Otacril, Mingit, Reomax, Uregit, Etakrinic acid, Methylenebutyrylphenoxyacetic acid, MK-595, Ethacrinique (acide), Acido etacrinico, Acide etacrynique, Acidum etacrynicum, Kyselina ethakrynova, Kyselina ethakrynova [Czech], [2,3-Dichloro-4-(2-methylenebutyryl)phenoxy]acetic acid, Acide etacrynique [INN-French], Acido etacrinico [INN-Spanish], Acidum etacrynicum [INN-Latin], (2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid, 2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid, Methylenebutyryl phenoxyacetic acid, 2,3-Dichloro-4-(2-methylenebutyl)phenoxyacetic acid, MK 595, NSC 85791, NSC 624008, BRN 1915060, Acetic acid, (2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy)-, Etacrynic acid [INN], 2,3-Dichloro-4-(2-methylenebutyryl)phenoxy acetic acid, (2,3-Dichloro-4-(2-methylenebutyryl)phenoxy)acetic acid, (4-(2-Methylenebutyryl)-2,3-dichlorophenoxy)acetic acid, 2-(2,3-Dichloro-4-(2-methylenebutanoyl)phenoxy)acetic acid, NSC-85791, CHEMBL456, NSC-624008, Acetic acid, [2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]-, Kyselina 4-(2-(1-butenyl)karbonyl)-2,3-dichlorfenoxyoctova [Czech], M5DP350VZV, 58-54-8 (free acid), MLS000069535, MLS002701928, CHEBI:4876, [2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid, Kyselina 4-(2-(1-butenyl)karbonyl)-2,3-dichlorfenoxyoctova, DTXSID3025257, Acetic acid, (2,3-dichloro-4-(2-methylenebutyryl)phenoxy)-, NSC85791, NSC624008, CAS-58-54-8, [4-(2-Methylenebutyryl)-2,3-dichlorophenoxy]acetic acid, NCGC00016260-05, 2-[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid, SMR000058600, [2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic acid, Ethacryinic Acid, DTXCID205257, Ethacrynic acid [USAN:BAN], [2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid, CCRIS 4638, HSDB 2136, Ethacrynic acid (USP), SR-01000003010, EINECS 200-384-1, UNII-M5DP350VZV, Etacrynsaure, Crinuril, Acetic acid, [2,3-dichloro-4-(2-methylenebutyryl)phenoxy]-, etacrynic-acid, Ethacrynic acid [USAN:USP], 1gsf, 2gss, Prestwick_671, Opera_ID_61, Spectrum_000813, Prestwick0_000259, Prestwick1_000259, Prestwick2_000259, Prestwick3_000259, Spectrum2_000097, Spectrum3_000425, Spectrum4_000544, Spectrum5_000680, E0526, bmse000134, SCHEMBL26353, BSPBio_000078, BSPBio_002010, ETACRYNIC ACID [JAN], ETHACRYNIC ACID [MI], KBioGR_001207, KBioSS_001293, MLS002548854, DivK1c_000900, Etacrynic acid (JP17/INN), SPECTRUM1500287, SPBio_000054, SPBio_002297, ETHACRYNIC ACID [HSDB], ETHACRYNIC ACID [USAN], 2,3-Dichloro-4-(2-methylenebutyryl)phenoxyacetic acid, BPBio1_000086, GTPL7179, ETACRYNIC ACID [MART.], ETHACRYNIC ACID [VANDF], ETACRYNIC ACID [WHO-DD], HMS502M22, KBio1_000900, KBio2_001293, KBio2_003861, KBio2_006429, KBio3_001230, NINDS_000900, GLXC-02567, HMS1568D20, HMS1920M16, HMS2089N17, HMS2091D17, HMS2095D20, HMS3259G03, HMS3712D20, Pharmakon1600-01500287, HY-B1640, Ethacrynic acid, >=97% (HPLC), Tox21_110335, Tox21_201102, BDBM50186231, CCG-38915, ETACRYNIC ACID [EP IMPURITY], MFCD00056693, NSC757026, s5561, WLN: QV1OR BG CG DVY2&U1, ETACRYNIC ACID [EP MONOGRAPH], ETHACRYNIC ACID [ORANGE BOOK], GST Inhibitor-2 (Ethacrynic acid)), AKOS003404732, Tox21_110335_1, DB00903, ETHACRYNIC ACID [USP MONOGRAPH], KS-1453, NC00450, NSC-757026, IDI1_000900, NCGC00016260-01, NCGC00016260-02, NCGC00016260-03, NCGC00016260-04, NCGC00016260-06, NCGC00016260-07, NCGC00016260-08, NCGC00016260-09, NCGC00016260-10, NCGC00016260-11, NCGC00016260-13, NCGC00022601-03, NCGC00022601-04, NCGC00022601-05, NCGC00258654-01, NCI60_041898, SBI-0051374.P003, DB-053221, AB00051988, CS-0013591, NS00009284, A51097, D00313, AB00051988-19, AB00051988_20, A831918, Q418571, SR-01000003010-2, SR-01000003010-3, BRD-K63630713-001-05-0, BRD-K63630713-001-15-9, [2,3-Dichloro-4-(2-ethylacryloyl)phenoxy]acetic acid #, Acetic acid,3-dichloro-4-(2-methylenebutyryl)phenoxy]-, Z1590781983, 2,3-DICHLORO-4-(2-METHYLENEBUTYRYL)PHENOXY)ACETATE, 4-(METHYLENEBUTYRYL)-2,3-DICHLOROPHENOXY)ACETIC ACID, Acetic acid,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]-, Ethacrynic acid, European Pharmacopoeia (EP) Reference Standard, Ethacrynic acid, United States Pharmacopeia (USP) Reference Standard, 2-(2,3-DICHLORO-4-(2-METHYLENE-1-OXOBUTYL)PHENOXY)ACETIC ACID, Etacrynic acid for system suitability, European Pharmacopoeia (EP) Reference Standard